These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


414 related items for PubMed ID: 16508891

  • 1. The complexity of the dopaminergic synapses and their modulation by antipsychotics.
    Leuner K, Müller WE.
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S15-20. PubMed ID: 16508891
    [Abstract] [Full Text] [Related]

  • 2. [Neurobiology in the neuropharmacology of antipsychotic drugs].
    Tassin JP.
    Encephale; 2006 Jan; 32 Pt 2():S6-7. PubMed ID: 16800077
    [No Abstract] [Full Text] [Related]

  • 3. The neurochemical circuitry of schizophrenia.
    Carlsson A.
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S10-4. PubMed ID: 16508890
    [Abstract] [Full Text] [Related]

  • 4. [Dopamine D2 and serotonin 5HT2 receptors: functions, interactions and clinical consequences in schizophrenia].
    Guise S, Soubrouillard C, Blin O.
    Encephale; 1997 Apr; 23 Spec No 2():10-6. PubMed ID: 9273300
    [Abstract] [Full Text] [Related]

  • 5. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.
    Wiesel FA.
    Br J Psychiatry Suppl; 1994 Apr; (23):65-70. PubMed ID: 7913610
    [Abstract] [Full Text] [Related]

  • 6. Integrating the neurobiology of schizophrenia. Preface.
    Abi-Dargham A, Guillin O.
    Int Rev Neurobiol; 2007 Apr; 78():xiii-xvi. PubMed ID: 17349855
    [No Abstract] [Full Text] [Related]

  • 7. Dopamine receptors and schizophrenia.
    Reynolds GP.
    Biochem Soc Trans; 1996 Feb; 24(1):202-5. PubMed ID: 8674664
    [No Abstract] [Full Text] [Related]

  • 8. Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia.
    Reynolds GP.
    Acta Psychiatr Scand Suppl; 1994 Feb; 380():36-40. PubMed ID: 7914046
    [Abstract] [Full Text] [Related]

  • 9. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.
    Guillin O, Demily C, Thibaut F.
    Int Rev Neurobiol; 2007 Feb; 78():377-95. PubMed ID: 17349867
    [Abstract] [Full Text] [Related]

  • 10. Cortical microcircuits in schizophrenia--the dopamine hypothesis revisited.
    Winterer G.
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S68-71. PubMed ID: 16508900
    [Abstract] [Full Text] [Related]

  • 11. Half a century of antipsychotics and still a central role for dopamine D2 receptors.
    Kapur S, Mamo D.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1081-90. PubMed ID: 14642968
    [Abstract] [Full Text] [Related]

  • 12. [The optimal level of dopaminergic neurotransmission].
    de Haan L.
    Ned Tijdschr Geneeskd; 2005 Jul 30; 149(31):1721-2. PubMed ID: 16114285
    [Abstract] [Full Text] [Related]

  • 13. [New pharmacological approaches to the treatment of schizophrenia].
    Uzbay IT.
    Turk Psikiyatri Derg; 2009 Jul 30; 20(2):175-82. PubMed ID: 19504368
    [Abstract] [Full Text] [Related]

  • 14. Role of dopamine D(2) receptors for antipsychotic activity.
    Ginovart N, Kapur S.
    Handb Exp Pharmacol; 2012 Jul 30; (212):27-52. PubMed ID: 23129327
    [Abstract] [Full Text] [Related]

  • 15. Do neurotensin receptor agonists represent a novel class of antipsychotic drugs?
    Cáceda R, Kinkead B, Nemeroff CB.
    Semin Clin Neuropsychiatry; 2003 Apr 30; 8(2):94-108. PubMed ID: 12728409
    [Abstract] [Full Text] [Related]

  • 16. Pathophysiology of schizophrenia and the role of newer antipsychotics.
    Risch SC.
    Pharmacotherapy; 1996 Apr 30; 16(1 Pt 2):11-4. PubMed ID: 8778681
    [Abstract] [Full Text] [Related]

  • 17. Neurotensin-dopamine interactions: relevance to schizophrenia and the action of antipsychotic drugs.
    Stowe ZN, Bissette G, Nemeroff CB.
    Yakubutsu Seishin Kodo; 1991 Feb 30; 11(1):49-59. PubMed ID: 1679273
    [Abstract] [Full Text] [Related]

  • 18. Evolution of schizophrenia drugs: a focus on dopaminergic systems.
    Nikam SS, Awasthi AK.
    Curr Opin Investig Drugs; 2008 Jan 30; 9(1):37-46. PubMed ID: 18183530
    [Abstract] [Full Text] [Related]

  • 19. Is active psychosis neurotoxic?
    McGlashan TH.
    Schizophr Bull; 2006 Oct 30; 32(4):609-13. PubMed ID: 16914639
    [Abstract] [Full Text] [Related]

  • 20. [Psychopharmacologic approaches to schizophrenic psychoses].
    Giacardy-Paty M, Soubrouillard C, Blin O.
    Encephale; 1995 Jun 30; 21 Spec No 3():3-8. PubMed ID: 7628339
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.